Pasar al contenido principal

Cannabinoides e inmunoregulación de los procesos alérgicos

IJCI-2016-27619

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i
Subprograma Subprograma Estatal de Incorporación
Convocatoria Juan de la Cierva Incorporación
Año convocatoria 2016
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD COMPLUTENSE DE MADRID

Cannabinoides e inmunoregulación de los procesos alérgicos

IJCI-2016-27619

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i
Subprograma Subprograma Estatal de Incorporación
Convocatoria Juan de la Cierva Incorporación
Año convocatoria 2016
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A compendium answering 150 questions on COVID‐19 and SARS‐CoV‐2

  • Riggioni, Carmen
  • Comberiat, Pasquale
  • Giovannini, Mattia
  • Agache, Ioana
  • Akdis, Mubeccel
  • Alves-Correia, Magna
  • Antó, Josep M.
  • Arcolaci, Alessandra
  • Azkur, Ahmet Kursat
  • Azkur, Dilek
  • Beken, Burcin
  • Boccabella, Cristina
  • Bousquet, Jean
  • Breiteneder, Heimo
  • Carvalho, Daniela
  • Vecillas, Leticia de las
  • Diamant, Zuzana
  • Eguiluz-Gracia, Ibon
  • Eiwegger, Thomas
  • Eyerich, Stephanie
  • Fokkens, Wytske
  • Gao, Ya-dong
  • Hannachi, Farah
  • Johnston, Sebastian L.
  • Jutel, Marek
  • Karavelia, Aspasia
  • Klimek, Ludfger
  • Moya, Beatriz
  • Nadeau, Kari C.
  • O'Hehir, Robin
  • O'Mahony, Liam
  • Pfaar, Oliver
  • Sanak, Marek
  • Schwarze, Jürgen
  • Sokolowska, Milena
  • Torres Jaén, María José
  • Veen, Willem van de
  • Zelm, Menno C. van
  • Wang, De Yun
  • Zhang, Luo
  • Jiménez Saiz, Rodrigo
  • Akdis, Cezmi A.
In December 2019, China reported the first cases of the coronavirus disease 2019 (COVID‐19). This disease, caused by the severe acute respiratory syndrome–related coronavirus 2 (SARS‐CoV‐2), has developed into a pandemic. To date, it has resulted in ~9 million confirmed cases and caused almost 500 000 related deaths worldwide. Unequivocally, the COVID‐19 pandemic is the gravest health and socioeconomic crisis of our time. In this context, numerous questions have emerged in demand of basic scientific information and evidence‐based medical advice on SARS‐CoV‐2 and COVID‐19. Although the majority of the patients show a very mild, self‐limiting viral respiratory disease, many clinical manifestations in severe patients are unique to COVID‐19, such as severe lymphopenia and eosinopenia, extensive pneumonia, a “cytokine storm” leading to acute respiratory distress syndrome, endothelitis, thromboembolic complications, and multiorgan failure. The epidemiologic features of COVID‐19 are distinctive and have changed throughout the pandemic. Vaccine and drug development studies and clinical trials are rapidly growing at an unprecedented speed. However, basic and clinical research on COVID‐19–related topics should be based on more coordinated high‐quality studies. This paper answers pressing questions, formulated by young clinicians and scientists, on SARS‐CoV‐2, COVID‐19, and allergy, focusing on the following topics: virology, immunology, diagnosis, management of patients with allergic disease and asthma, treatment, clinical trials, drug discovery, vaccine development, and epidemiology. A total of 150 questions were answered by experts in the field providing a comprehensive and practical overview of COVID‐19 and allergic disease., NHMRC Senior Research Fellowship, Grant/ Award Number: GNT1117687; Consejo Superior de Investigaciones Científicas, Grant/Award Number: IJCI-2016-27619; Instituto de Salud Carlos III, Grant/Award Number: JR19/0029, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Immunology of COVID‐19: mechanisms, clinical outcome, diagnostics and perspectives – a report of the European Academy of Allergy and Clinical Immunology (EAACI)

  • Sokolowska, Milena
  • Lukasik, Z.
  • Agache, Ioana
  • Akdis, Cezmi A.
  • Akdis, D.
  • Akdis, Mubeccel
  • Barcik, Weronika
  • Brough, Helen
  • Eiwegger, Thomas
  • Eljaszewicz, Andrzej
  • Eyerich, Stephanie
  • Feleszko, Wojciech
  • Gómez-Casado, C.
  • Hoffmann-Sommergruber, Karin
  • Janda, Jozef
  • Jiménez Saiz, Rodrigo
  • Jutel, Marek
  • Knol, Edward
  • Krohn, Kortekaas
  • Kothari, Akash
  • Makowska, J.
  • Moniuszko, Marcin
  • Morita, Hideaki
  • O’Mahony, L.
  • Nadeau, Kari C.
  • Ozdemir, Cevdet
  • Pali-Schöll, Isabella
  • Palomares, O.
  • Papaleo, Francesco
  • Prunicki, Mary
  • Schmidt-Weber, C. B.
  • Sediva, A.
  • Schwarze, Jürgen
  • Shamji, M. H.
  • Tramper-Stranders, Gerdien
  • Veen, Willem van de
  • Untersmayr, Eva
With the worldwide spread of the novel Severe Acute Respiratory Syndrome Coronavirus‐2 (SARS‐CoV‐2) resulting in declaration of a pandemic by the World Health Organization (WHO) on March 11, 2020, the SARS‐CoV‐2‐induced Coronavirus disease‐19 (COVID‐19) has become one of the main challenges of our times. The high infection rate and the severe disease course led to major safety and social restriction measures worldwide. There is an urgent need of unbiased expert knowledge guiding the development of efficient treatment and prevention strategies. This report summarizes current immunological data on mechanisms associated with the SARS‐CoV‐2 infection and COVID‐19 development and progression to the most severe forms. We characterize the differences between adequate innate and adaptive immune response in mild disease and the deep immune dysfunction in the severe multi‐organ disease. The similarities of the human immune response to SARS‐CoV‐2 and the SARS‐CoV and MERS‐CoV are underlined. We also summarize known and potential SARS‐CoV‐2 receptors on epithelial barriers, immune cells, endothelium and clinically involved organs such as lung, gut, kidney, cardiovascular and neuronal system. Finally, we discuss the known and potential mechanisms underlying the involvement of comorbidities, gender and age in development of COVID‐19. Consequently, we highlight the knowledge gaps and urgent research requirements to provide a quick roadmap for ongoing and needed COVID‐19 studies., The authors would like to thank the European Academy of Allergy and Clinical Immunology (EAACI) for the financial support to the sections, interest groups and working groups enabling the development of this paper. The research of SM is supported by a SNSF grant 310039_189334; JSR is funded by Ministerio de Economía y Competitividad (IJCI-2016-27619); KKI is supported by the FWO Post doc mandate 12W2219N; BW and PF were supported by funding from the Istituto Italiano di Tecnologia, Fondazione Telethon (project GGP19103), and Ricerca Finalizzata Giovani Ricercatori 2016 - Ministero Salute Italia (project GR-2016-02362413); GCC is supported by a postdoctoral contract cofounded by the competitive Program “Attracting Talent,” Community of Madrid, Spain; the research of SWCB was funded by DFG (398577603), “ADAPT” EIT Health is a body of the EU receiving support from H2020 and BMBF “ESCAPE” 01KI20169A; the research of UE is supported by the H2020 grant 768641 and by the BMF grant 19056., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Is hybrid-PBL advancing teaching in biomedicine? A systematic review

  • Jiménez Saiz, Rodrigo
  • Rosace, Domenico
[Background]: The impact of instructional guidance on learning outcomes in higher biomedical education is subject of intense debate. There is the teacher-centered or traditional way of teaching (TT) and, on the other side, the notion that students learn best under minimal guidance such as problem-based learning (PBL). Although the benefits of PBL are well-known, there are aspects susceptible to improvement. Hence, a format merging TT and PBL (hybrid-PBL, h-PBL) may advance education in biomedical sciences., [Methods]: Studies that employed h-PBL in higher biomedical education compared to TT and/or pure PBL were systematically reviewed. Specifically, this review addressed the following question: does h-PBL in biomedical sciences result in superior marks and a better student’s perception of the teaching and learning process?, [Results]: We found that the use of h-PBL in higher biomedical sciences was superior compared to TT and pure-PBL. This was evidenced by the higher performance of the students in h-PBL as well as the level of student’s satisfaction as compared to TT or pure PBL., [Conclusions]: These findings encourage more research on investigating the pedagogical benefits of h-PBL. In addition, these data support an eclectic system in which the pedagogical tools from TT and PBL are used cooperatively in the best interest of the education and satisfaction of the students., This study was funded by a Juan de la Cierva research grant from the Spanish Ministry of Economy and Competitiveness to RJS (IJCI-2016-27619)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Follicular T cells: from stability to failure

  • Jiménez Saiz, Rodrigo
  • Bruton, Kelly
  • Jordana, Manel
The germinal center (GC) reaction is key for adaptive immunity as it drives the generation of high‐affinity antibodies that mediate protection against extracellular pathogens. This process entails extensive B‐cell proliferation, somatic hypermutation of the B‐cell receptor, and affinity maturation. While the GC reaction provides an evolutionary advantage, its dysregulation can trigger the development of diseases such as autoimmunity, hypersensitivity, and cancer. Immune regulation, such as the one exerted by regulatory T cells, is a central immunological principle aimed at maintaining homeostasis and preventing pathological responses.1 At the level of the GC, the precise role of follicular regulatory T cells (TFR) has remained elusive, and even controversial, due to limitations of the current experimental systems., Ministerio de Economía y Competitividad (IJCI‐2016‐27619).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Single-cell RNA analysis: guiding the treatment of DiHS/DRESS

  • Beken, Burcin
  • Arcolaci, Alessandra
  • Jiménez Saiz, Rodrigo
Drug‐induced hypersensitivity syndrome (DiHS)—also termed as drug reaction with eosinophilia and systemic symptoms (DRESS)—is a potentially lethal inflammatory disease associated with human herpesvirus (HHV) reactivation. DiHS/DRESS is classified within a group of syndromes named severe cutaneous adverse reactions (SCARs), including acute generalized exanthematous pustulosis and Stevens‐Johnson syndrome/toxic epidermal necrolysis. SCARs are delayed type IV hypersensitivity reactions mainly characterized by T‐cell activation. The most commonly encountered dermatological manifestation of DRESS is an erythematous morbilliform rash, sometimes complicated by vesicles, bullae, atypical targetoid plaques, purpura, or sterile small pustules, or even progress to exfoliative dermatitis or erythroderma. The pathophysiology of DRESS is still poorly understood.1 The proposed mechanisms implicated in its pathogenesis include drug detoxification enzyme abnormalities, sequential reactivation of herpesviruses (cytomegalovirus, Epstein‐Barr virus, HHV‐6 and ‐7), and genetic predisposition related to certain human leukocyte antigen alleles. The limited knowledge of the mechanisms and pathways underlying the pathology of DRESS present an important treatment hurdle., Ministerio de Economía y Competitividad. Grant Number: IJCI‐2016‐27619
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The neuroimmunological toll of nutrient absorption

  • Palma, Giada de
  • Caminero, Alberto
  • Jiménez Saiz, Rodrigo
The innate immune lymphocytes (ILCs), discovered about a decade ago, exhibit functional features of T cells but lack antigen‐specific receptors (ie, TCR). ILCs modulate mucosal immunity, inflammation, and tissue homeostasis.1 Among them, ILC3s express retinoid‐related orphan receptor γt (RORγt) transcription factor and produce IL‐22 and IL‐17, actively maintaining tissue homeostasis., RJS is funded by Ministerio de Economía y Competitividad (IJCI‐2016‐27619).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Drug‐induced IgG‐neutrophil‐mediated anaphylaxis in humans: Uncovered!

  • Jiménez Saiz, Rodrigo
Seminal work by Oettgen et al1 in the early 90s revealed the existence of alternative pathways of anaphylaxis (non‐IgE‐mediated) in IgE‐deficient mice. These are mediated by IgG‐immune complexes that, depending on their nature, signal on a number of myeloid cells including macrophages/monocytes, basophils, mast cells, and neutrophils. While extensively characterized in mice, conclusive evidence of the existence of alternative pathways of anaphylaxis in humans has remained elusive. This is partly due to the rarity of these complex reactions and the scarcity of biomarkers to identify them as well as experimental systems to tease apart their contribution from that of the classical pathway (IgE‐mediated), Ministerio de Economía y Competitividad. Grant Number: IJCI‐2016‐27619